Stock Price Quote

SOLVAY PHARMA INDIA LTD. (AMALGAMATED)

NSE : NABSE : 532447ISIN CODE : INE593D01010Industry : Pharmaceuticals & DrugsHouse : Solvay Pharma - MNC
BSE2141.550 (0 %)
PREV CLOSE ( ) 2141.55
OPEN PRICE ( ) 2150.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 81
TODAY'S LOW / HIGH ( )2140.00 2150.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1999
Management Info
Roland Kaut - Chairman Niteen B Gadgil - Managing Director
Registered Office

Address 271, Business Park,6th &7th Floors,Model Industrial Colony,off Aarey Road,Goregaon (East),
Mumbai,
Maharashtra-400063

Phone 91-22-2871 7400/91-22-4244-7400

Email info@solvaypharma.co.in

Website www.solvaypharma.co.in

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE

NEWS

16Jul Solvay Pharma India gets HC nod for sc
Solvay Pharma India has received an approval from High Court of Bombay,..
06Apr Solvay Pharma India declares dividend
Solvay Pharma India has informed that the dividend when declared at the..
11Feb Solvay Pharma India board recommends d
Solvay Pharma India has informed that the board of directors of the comp..
29Jan Solvay Pharma India board to consider
Solvay Pharma India has informed that a meeting of the board of director..
17Feb Abbott concludes acquisition of Solvay
Mumbai-based Solvay Pharma India has said that US-based Abbott Laborator..

Financials

in Millions
QTR Mar 11 ANNUAL 10
Net Profit112.09508.49
Gross Profit 165.13 758.43
Operating Profit 228.82790.54
Net Sales 808.932969.09

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

RPG Life Sciences (BSE)
peergroup  2325.00 (3.68%)
M.Cap ( in Cr)3757.50
Albert David (BSE)
peergroup  1510.00 (5.64%)
M.Cap ( in Cr)807.56
Everest Organics (BSE)
peergroup  212.60 (19.98%)
M.Cap ( in Cr)169.96
NGL Fine-Chem (BSE)
peergroup  1874.00 (1.73%)
M.Cap ( in Cr)1157.64
Glenmark Pharma (BSE)
peergroup  1542.70 (1.91%)
M.Cap ( in Cr)43907.07

Shareholding Pattern

PROMOTERS 88.85%
NON-INSTITUTION 11.14%
FI/BANKS/INSURANCE 0.01%
FII 0.01%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%

About Solvay Pharma India Ltd. (Amalgamated)

Solvay Pharma India Ltd. (Amalgamated) was incorporated in the year 1999. Its today's share price is 2141.55. Its current market capitalisation stands at Rs 1081.42 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3020.21 Cr and Total Income of Rs.3005.95 Cr. The company's management includes M S Grewal, S N Talwar, D G Rajan, Roland Kaut.

It is listed on the BSE with a BSE Code of 532447 , NSE with an NSE Symbol of and ISIN of INE593D01010. It's Registered office is at 271, Business Park,6th &7th Floors,Model Industrial Colony,off Aarey Road,Goregaon (East)Mumbai-400063, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloittee Haskins & Sells

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.